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The hypothalamic–pituitary–adrenal (HPA) axis plays a key role in adaptation to
environmental stresses. Parvicellular neurons of the hypothalamic paraventricular nucleus
secrete corticotrophin releasing hormone (CRH) and arginine vasopressin (AVP) into pitu-
itary portal system; CRH and AVP stimulate adrenocorticotropic hormone (ACTH) release
through specific G-protein-coupled membrane receptors on pituitary corticotrophs, CRHR1
for CRH and V1b for AVP; the adrenal gland cortex secretes glucocorticoids in response to
ACTH.The glucocorticoids activate specific receptors in brain and peripheral tissues thereby
triggering the necessary metabolic, immune, neuromodulatory, and behavioral changes to
resist stress. While importance of CRH, as a key hypothalamic factor of HPA axis regula-
tion in basal and stress conditions in most species, is generally recognized, role of AVP
remains to be clarified. This review focuses on the role of AVP in the regulation of stress
responsiveness of the HPA axis with emphasis on the effects of aging on vasopressinergic
regulation of HPA axis stress responsiveness. Under most of the known stressors, AVP is
necessary for acute ACTH secretion but in a context-specific manner. The current data on
the AVP role in regulation of HPA responsiveness to chronic stress in adulthood are rather
contradictory.The importance of the vasopressinergic regulation of the HPA stress respon-
siveness is greatest during fetal development, in neonatal period, and in the lactating adult.
Aging associated with increased variability in several parameters of HPA function including
basal state, responsiveness to stressors, and special testing. Reports on the possible role
of the AVP/V1b receptor system in the increase of HPA axis hyperactivity with aging are
contradictory and requires further research. Many contradictory results may be due to age
and species differences in the HPA function of rodents and primates.
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INTRODUCTION
The hypothalamic–pituitary–adrenal (HPA) axis is a key adaptive
neuroendocrine system. Regulation of glucocorticoid secretion
through adrenocorticotropic hormone (ACTH) is critical to life
and essential to maintain the mammalian response to stressor
(Pedersen et al., 2001; McEwen, 2007; Lupien et al., 2009). The HPA
axis consists of the nucleus paraventricularis hypothalami (PVN),
which secretes corticotrophin releasing hormone (CRH) and argi-
nine vasopressin (AVP); the pituitary gland that is sensitive to CRH
and AVP, which stimulate ACTH release; the adrenal gland cor-
tex, which secretes the glucocorticoids, mainly cortisol in humans
and non-human primates, and corticosterone in rodents, and
dehydroepiandrosterone (DHEA) in humans and non-human pri-
mates in response to interaction with ACTH. DHEA and its sulfate
DHEAS are important regulators of glucocorticoid activity (Yen
and Laughlin, 1998; Maninger et al., 2009). The glucocorticoids
act on specific receptors present in most peripheral tissues and the
brain and trigger the metabolic, immune, neuromodulatory, and
behavioral changes needed to cope with the impact of the stressors
(Tuckermann et al., 2005; McEwen, 2007; Vegiopoulos and Herzig,
2007). In turn, the glucocorticoids act through the pituitary and
limbic structures, especially the hippocampus, in a negative feed-
back loop to regulate the activity of CRH-producing neurons in
the PVN and, thus the entire the HPA axis. The adaptive influence
of the HPA axis under stress is realized not only through ACTH
and the corticosteroids but also through the hypothalamic neu-
ropeptides CRH and AVP, which are released in the brain, where
they are responsible for behavioral and autonomic responses to
stress (Bale and Vale, 2004; Roper et al., 2011).
In resting conditions, activity of the HPA axis shows circa-
dian and ultradian changes with pulsatile glucocorticoid secre-
tion that is greater in amplitude during the phase of wake-
fulness. This leads to higher average levels of glucocorticoids
during the day in humans and most other primates and to
higher activity of the HPA axis during the night in rodents
(Goncharova et al., 2002; Kalsbeek et al., 2010; Russell et al.,
2010; Walker et al., 2010). Stress responsiveness of the pituitary–
adrenal axis in humans and non-human primates also shows the
www.frontiersin.org March 2013 | Volume 4 | Article 26 | 1
Goncharova HPA axis age-related features
circadian rhythms with higher stress response in the afternoon
and evening, and lower in the morning (Goncharova, 2006; Gon-
charova et al., 2006a; De Weerth et al., 2007). Rhythmicity in the
HPA axis is essential for the normal functioning of the brain and
other glucocorticoid responsive organs (Van Cauter et al., 1997;
Lupien et al., 2002; Yoshimura et al., 2007; Goncharova et al.,
2008a,b).
While the acute stress activation of the HPA axis is critical for
life, chronic exposure to stressors leads to its excessive stimulation
and hypercortisolemia. Hypercortisolemia plays a pathophysio-
logical role in the development of a variety of stress-related dis-
eases: psychiatric, reproductive, immune, metabolic, and others.
It is a major factor in aging and age-related pathology (Chrousos,
2000; de Kloet et al., 2005, 2008; Perez-Neri et al., 2008). While
CRH is widely recognized as a major hypothalamic factor con-
trolling the HPA axis activity in resting conditions and under
stress, the role of AVP in regulation of the HPA axis remains
to be studied. Almost all current data on the role of AVP in
regulation of the HPA axis were obtained in experiments on
adult rodents. In the available literature, there are no review
articles devoted to the role of AVP in the regulation of HPA
axis stress responsiveness in aged subjects. In any event, aging is
generally characterized by hyperactivation of the HPA axis, break-
down of the circadian rhythm, progressive decline in DHEA and
DHEAS production, and high incidence of stress-dependent dis-
eases, including depression, in which AVP production and the
corticosteroids are of great importance (Yen and Laughlin, 1998;
de Winter et al., 2003; Dinan and Scott, 2005; Kondratova and
Kondratov, 2012). This review will focus on the evaluation of the
role of AVP in the regulation of stress responsiveness of the HPA
axis with emphasis on HPA axis vasopressinergic regulation dur-
ing healthy aging in rodents as well as in humans and non-human
primates.
MECHANISMS OF HPA AXIS REGULATION
CORTICOTROPHIN RELEASING HORMONE
Corticotrophin releasing hormone is the main physiological regu-
lator of the HPA axis in basal conditions and in response to most
acute stressors (Jacobson et al., 2000; Bale and Vale, 2004; Aguil-
era, 2011). CRH is a peptide consisting of 41 amino acid residues,
which was discovered and sequenced by Vale et al. (1983). It is
produced in the medial parvicellular neurons of the PVN, which
project to the outer zone of the median eminence. There it is
released into the portal system of the pituitary, which reaches the
anterior lobe. CRH stimulates ACTH secretion through activation
of type 1 CRH receptors (CRHR1) in the pituitary corticotrophs.
CRHR1 belongs to the CRH family of G-protein-coupled mem-
brane receptors (GPCRs) (Bale and Vale, 2004; Zorrilla and Koob,
2010).
The collection of CRH-producing neurons (CRH neurons) of
the PVN is a key center of the central nervous system, integrating
the neuroendocrine effects of stress, and a key part of the HPA axis.
On the one hand, the CRH neuron is under the regulatory influ-
ence of numerous afferent nerve pathways that carry information
about the stressor. In addition, it is regulated by glucocorticoids
and it is the central link of the autoregulation mechanism in the
HPA axis.
Afferent regulation
The CRH neuron receives projections from ascending cate-
cholaminergic pathways including noradrenergic projections from
the A2 noradrenergic cell group within the nucleus of the solitary
tract and the locus ceruleus. It also receives input from areas of
the limbic system, notably the bed nucleus of the stria terminalis,
the hippocampus, and the amygdala (Herman et al., 1996; Dinan
and Scott, 2005). Indirect pathways from the sensory systems in
the forebrain through the amygdala and bed nucleus of the stria
terminalis may stimulate CRH neurons by activating stimulatory
(glutamatergic) or repressing inhibitory (γ-aminobutyric acid –
GABA-ergic) interneurons (Herman et al., 1996; Arvat et al., 2002;
Aguilera, 2011). There is also significant evidence in relation to
the stimulatory effect of the cholinergic system on CRH secretion
implemented through direct and indirect projections from both
the basal forebrain and the mesopontine tegmentum (Rhodes and
Rubin, 1999; Rubin and Rhodes, 2002).
Glucocorticoid feedback mechanism
Feedback mechanism plays an essential role in the regulation of
CRH production and in limiting the stress response. The central
sensors of feedback to the HPA axis are two corticosteroid recep-
tors, the high-affinity mineralocorticoid receptor (MR) and the
low-affinity glucocorticoid receptors (GR), which are expressed in
the brain and on the corticotrophs of the pituitary (Ratka et al.,
1989). GRs are distributed throughout the brain, but mostly in
hypothalamic neurons and corticotrophs (Jacobson and Sapolsky,
1991; Funder, 1997), whereas MRs are present in the hypothala-
mus and in the greatest numbers in the hippocampus (Ratka et al.,
1989; Funder, 1997). A significant role of direct inhibition of tran-
scription of pro-opiomelanocortin (POMC) and ACTH secretion
by glucocorticoids in the regulation of the HPA axis by a feedback
mechanism has been previously demonstrated (Autelitano et al.,
1989; Dallman et al., 1994). Development of MR antagonists has
enabled demonstration of the important role of glucocorticoid
feedback at the suprapituitary level, probably from the hippocam-
pus in regulation of the HPA axis both in animals and humans
(Wellhoener et al., 2004; Giordano et al., 2005). The presence of
GRs in CRH neurons (Liposits et al., 1987), as well as a demon-
strated inhibitory effect of intra-PVN glucocorticoid injection on
CRH mRNA, and the reduction in CRH promoter activity in
reporter gene assays following incubation with glucocorticoids,
give reason to believe that a direct inhibitory effect of glucocorti-
coids on CRH transcription underlies the central mechanisms of
feedback regulation of CRH transcription and desensitization of
the HPA axis to stress responses (Kovacs et al., 1986; Sawchenko,
1987; Harbuz and Lightman, 1989; Makino et al., 1995; Fenoglio
et al., 2004; Aguilera, 2011).
ARGININE VASOPRESSIN
Distribution of AVP
While it is generally accepted that CRH is a critical coordinator of
HPA axis function in resting conditions and in response to stress
(Aguilera, 1998, 2011; Jacobson et al., 2000; Bale and Vale, 2004),
the role of AVP in the regulation of the HPA axis remains a sub-
ject of active research. Following its identification in 1954, AVP, a
nonapeptide, was considered the principal factor in the regulation
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of ACTH secretion until the subsequent identification of CRH,
which led to the replacement of AVP with CRH as the principle
regulator of the HPA axis. Nevertheless, AVP is still considered
as an important regulator of the HPA axis (Antoni, 1993; Her-
man, 1995; Volpi et al., 2004; Aguilera, 2011). In addition, AVP is
seen as a hormonal regulator of water homeostasis and has sig-
nificant effects on vascular tone (Knepper, 1997; Koshimizu et al.,
2006). AVP is also believed to regulate circadian rhythms (Kals-
beek et al., 2010; Kondratova and Kondratov, 2012) and numerous
central functions such as synaptic transmission, control of body
temperature, memory, and behavior (Barberis and Tribollet, 1996;
Wersinger et al., 2002).
Knowledge of the functional anatomy, physiology, and patho-
physiology of AVP in the regulation of the HPA axis is mainly
based on studies carried out on rodents. There are two major
vasopressinergic systems in the brain. The first system consists of
hypothalamic magnocellular neurons in the PVN and supraoptic
nucleus, which project to the neurohypophysis and deliver AVP
and oxytocin to the peripheral circulation; it is largely responsible
for the peripheral actions of AVP that maintain water homeostasis
and blood pressure (Knepper, 1997; Koshimizu et al., 2006). The
second system is represented by the CRH-producing parvicellular
neurons of the PVN, which also synthesizes AVP. AVP produced
by the latter neuron is secreted into the pituitary portal circulation
from axon terminals in the external zone of the median eminence;
they are involved in regulation of the HPA axis (Antoni, 1993). It
has been shown in non-stressed rats that 50% of CRH neurose-
cretory cells coexpress AVP (Whitnall, 1987). In humans, there
is evidence that all CRH neurons in the hypothalamus may con-
tain AVP (Mouri et al., 1993; Dinan and Scott, 2005). In primates,
including humans, large numbers of immunoreactive AVP neu-
rons have been demonstrated in the limbic system, notably the bed
nucleus of the stria terminalis, the hippocampus and the amyg-
dala, and also in the pituitary intermediate lobe, the granular layers
of cerebellar cortex, and the dentate gyrus. Lower levels are found
in the medial habenula, adenohypophysis, area postrema, pineal
body, subfornical and subcommissural organs (see review Dinan
and Scott, 2005). It is thought that the AVP levels in the pituitary
portal vascular system is derived from the PVN, but morpholog-
ical and neurochemical studies suggest that AVP from supraoptic
magnocellular AVP-secreting cells also accesses the hypophyseal
portal blood (Antoni et al., 1990; Dinan and Scott, 2005). AVP
neurons in the medial amygdala and the bed nucleus of the stria
terminalis project to the lateral septum and ventral hippocampal
sites affecting memory and behavior (Caff et al., 1987; Aguilera,
2011). Finally, AVP is expressed in the suprachiasmatic nucleus
(SCN), which is involved in the regulation of circadian rhythms
(Rhodes and Rubin, 1999; Arima et al., 2002; Kalsbeek et al., 2010;
Kondratova and Kondratov, 2012).
AVP receptors
The actions of AVP are mediated through interaction with spe-
cific plasma membrane receptors of target cells that have been
identified and cloned (Jard et al., 1987; Birnbaumer, 2000; Derick
et al., 2004). AVP receptors belong to the family of GPCRs, i.e., they
transmit a signal to the cell through G-protein (guanyl-nucleotide-
binding protein) (Jard et al., 1987; Birnbaumer, 2000; Thibonnier
et al., 2002; Derick et al., 2004). AVP receptors have been divided
into three major types: V1a,V1b (or V3), and V2 according to their
pharmacological and G-protein-coupled properties. The V1a and
V1b subtypes are both coupled to Gq and signal via phospholipase
C (Jard et al., 1987; Thibonnier et al., 2002; Roper et al., 2011).
The V2 receptor subtype is coupled to Gs that signal via adenylate
cyclase (Thibonnier et al., 2002; Derick et al., 2004). The V1a recep-
tor is predominantly found in vascular smooth muscle where it is
involved in control of vasoconstrictor effects and blood pressure
(Koshimizu et al., 2006; Vantyghem et al., 2011). The renal V2 AVP
receptor is responsible for water resorption in collecting ducts of
the kidney by promoting the translocation of aquaporin-2 chan-
nels to the plasma membrane (Knepper, 1997). The V1b receptor is
primarily located in corticotrophs of the anterior pituitary where it
stimulates ACTH release (Antoni, 1993; Derick et al., 2004; Roper
et al., 2011). A number of studies utilizing in situ hybridization his-
tochemistry and reverse transcription-polymerase chain reaction
in rodents have shown that V1b receptor mRNA is also expressed at
a lower level in some brain regions (hippocampus, PVN, olfactory
bulb, and amygdala) and a number of peripheral tissues (kidney,
pancreas, heart, lung, breast, adrenal medulla, and others) (Grazz-
ini et al., 1996; Roper et al., 2011), where its function is unknown
(Roper et al., 2011).
Effects of AVP on the HPA axis function and interaction with CRH
The ability of both neuropeptides CRH and AVP to stimulate the
secretion of ACTH has been demonstrated in humans (DeBold
et al., 1984; Salata et al., 1988; Favrod-Coune et al., 1993) and vari-
ous other species, including non-human primates (Goncharova
and Lapin, 2002; Goncharova, 2009a), rats (Vale et al., 1983;
Antoni, 1993), mice (Muller et al., 2000; Lolait et al., 2007), horses
(Evans et al., 1993), and sheep (McFarlane et al., 1995; Hassan et al.,
2003). The relative importance of each seems to vary depending on
the species. For example, in humans (DeBold et al., 1984; Favrod-
Coune et al., 1993), non-human primates (Goncharova, 2009a),
rats (Vale et al., 1983; Antoni, 1993; Serradeil-Le Gal et al., 2005),
and horses (Evans et al., 1993), CRH is a much more potent sec-
retagogue than AVP. At the same time, some groups have reported
that in the sheep AVP is the more potent secretagogue (Familari
et al., 1989; Hassan et al., 2003). In all cases, a marked syner-
gism between CRH and AVP has been observed (Antoni, 1993;
Favrod-Coune et al., 1993; Aguilera et al., 1994; Aguilera, 1998;
Serradeil-Le Gal et al., 2005). The impact of AVP on ACTH secre-
tion is often regarded as ancillary to CRH as far as AVP alone is
a weak ACTH secretagogue but acts synergistically with CRH to
facilitate ACTH release both in humans (DeBold et al., 1984; Salata
et al., 1988; Favrod-Coune et al., 1993) and rodents (Rivier and
Vale, 1983; Antoni, 1993). It has been shown that the corticotroph
AVP/V1b and the CRH/CRHR1 signaling pathways converge to
increase ACTH secretion (Abou-Samra et al., 1986; Roper et al.,
2011). In particular, it has been suggested that AVP plays a role
in stimulating the primary nuclear transcripts induced by CRH
in pituitary corticotrophs (Antoni, 1993). Studies in recent years
suggest that the CRH–AVP synergism may also be conditioned
by change in the physical state of corticotroph V1b and CRHR1
receptors (Young et al., 2007; Roper et al., 2011). The two receptors
may physically heterodimerize (Young et al., 2007).
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VASOPRESSINERGIC REGULATION OF STRESS
RESPONSIVENESS OF THE HPA AXIS
AVP IN REGULATION OF HPA AXIS REACTIVITY IN RESPONSE TO ACUTE
STRESS
Acute stress
Acute immobilization stress has been observed to lead to up-
regulation of AVP mRNA along with up-regulation of CRH mRNA
expression in parvicellular neurons of the PVN (Bartanusz et al.,
1993). Moreover, compensatory increase in basal vasopressinergic
system in mice lacking the CRHR1 gene was revealed (Muller et al.,
2000). All this allows us to consider AVP as an important modula-
tor of the ACTH response to stress, as a compensatory mechanism
to maintain the activity of the HPA axis when the CRH/CRHR1
signaling pathway is damaged (Muller et al., 2000). The impor-
tance of AVP along with CRH as physiological modulators of
ACTH secretion in response to insulin-induced hypoglycemia has
been demonstrated in humans (DeBold et al., 1984; Ellis et al.,
1990).
The precise role of AVP production in response to stress
remains controversial because most studies have involved indi-
rect or correlative measurements of activation of AVP-producing
neurons after exposure to stress (DeBold et al., 1984; Ellis et al.,
1990; Makara et al., 2004; Lolait et al., 2007). Some of the best
evidence for AVP involvement in the response of the HPA axis
response to stress is derived from studies that have shown that
immunoneutralization of AVP diminish the increase in plasma
ACTH produced by various stressors such as restraint, insulin-
induced hypoglycemia, or injection of bacterial lipopolysaccharide
(LPS) (Turnbull et al., 1998; see introduction in Lolait et al.,
2007). In addition, studies in which AVP levels have been sam-
pled in pituitary portal blood indicate that AVP may be secreted
preferentially over CRH in response to acute stressors such as
insulin-induced hypoglycemia (Plotsky et al., 1985; Engler et al.,
1989).
Nevertheless, several studies do not support the conclusion of
an important role for AVP in the regulation of HPA axis stress
responsiveness. Animals in some studies using modern genetic
and pharmacological models to create an AVP deficit have, nev-
ertheless shown a normal response of the HPA axis in acute
stress, specifically to restraint, resident-intruder, and LPS stres-
sors (Lolait et al., 2007; Chen et al., 2008a; Zelena et al., 2011).
For example, mice lacking AVP V1b receptors exhibited normal
corticosterone responses to acute physical–psychological stress in
the resident-intruder paradigm (Wersinger et al., 2002).
In other studies using genetic and pharmacological models of
AVP deficit the pituitary–adrenal responses to acute stress were
substantially reduced. Thus, recent studies with the V1b recep-
tor knockout mice demonstrated reduced plasma levels of ACTH
and corticosterone or only ACTH in response to insulin-induced
hypoglycemia (Lolait et al., 2007), forced-swimming (Tanoue et al.,
2004; Stewart et al., 2008),novel environment (Stewart et al., 2008),
mild restraint (Stewart et al., 2008), and in response to some of the
other stressors (Roper et al., 2011) compared to wild-type mice.
The use of SSR149415, the first selective V1b receptor antago-
nist, at 2 h after treatment significantly suppressed the increase
in ACTH after a 5 min forced-swimming stress and decreased
the dramatic elevation in plasma corticosterone concentrations
in mice (Serradeil-Le Gal et al., 2005). Acute administration of
another antagonist of V1b receptor (Org) also reduced ACTH
secretion following both restraint and LPS but did not antago-
nize the ACTH response to noise (Spiga et al., 2009). Interestingly,
the Org V1b antagonist, while reducing the stress-induced increase
in ACTH secretion, had no effect on plasma corticosterone levels
(Spiga et al., 2009). Similar results were obtained when another
V1b receptor antagonist (SSR149415) was used: the ACTH plasma
level was reduced in rats in response to restraint compared to
controls, but showed no inhibitory effect on the secretion of
corticosterone (Serradeil-Le Gal et al., 2003).
Findings from studies of the role of AVP in responsiveness of
the HPA axis in acute stress using V1b receptor antagonists in
rodents are consistent with studies of naturally AVP-deficient Brat-
tleboro rats (Zelena et al., 2009; Makara et al., 2012). The ACTH
response of homozygous animals to severe stressors, such as those
mentioned above, as well as to anaphylactoid stress (hypertonic
saline, egg white injection), elevated plus-maze, and novelty, was
sharply decreased compared to that of heterozygous littermates.
The ACTH response also was decreased in response to volume
load, restraint, or aggressive attack in AVP-deficient rats. At the
same time, there were no significant differences in the ACTH reac-
tion in response to such stressors as social avoidance, footshock,
and ether inhalation. Differences were also observed in the cor-
ticosterone response to the three groups of stressors. It did not
change in response to the first group of stressors, decreased in par-
allel with ACTH in AVP-deficient rats in response to the second
group of stressors and, like ACTH, did not change, in response
to the third group of stressors (Zelena et al., 2009; Makara et al.,
2012). Herman et al. (1996) and Zelena et al. (2009) suggest that
the brain categorizes stressors and utilizes neural response path-
ways that vary in accord with their assigned category as well as that
AVP increase the ACTH response to stress in a context-specific
manner (Zelena et al., 2009).
Age can also influence the importance of AVP for the HPA axis
response to acute stress. Reduced ACTH and corticosterone release
was observed in AVP-deficient rats in the neonatal period, while
adult rats of the same strain demonstrated a normal response of
the pituitary–adrenal axis to LPS injection (Zelena et al., 2011).
Basal conditions
There is a wide range of studies on the role of AVP in the HPA
axis regulation not only in response to acute stressors but dur-
ing basal conditions. Studies using AVP immunoneutralization
have not identified a role of AVP in basal ACTH regulation (Ono
et al., 1985; Tilders et al., 1985). Studies using genetic models of
AVP deficit based on knocking out the corticotroph V1b recep-
tor resulted either in reduced (Tanoue et al., 2004) or normal
(Lolait et al., 2007) resting ACTH and corticosterone levels. A
selective V1b receptor antagonist (Org), which decreased restraint-
and LPS-induced ACTH secretion, did not affect the resting lev-
els or stress-induced corticosterone responses (Spiga et al., 2009).
The resting pituitary ACTH concentration of homozygous Brat-
tleboro rats appeared to be normal (Lolait et al., 1986; Zelena et al.,
2009), although there was a trend toward elevated corticosterone
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at decapitation (Zelena et al., 2009) and also there are publications
of impaired basal ACTH and corticosterone plasma levels (Burgess
and Balment, 1992).
AVP REGULATION OF HPA AXIS RESPONSIVITY TO CHRONIC STRESS
Regulation of V1b receptors in the pituitary gland appears to play
a major role in corticotroph responses to chronic stressors, as a
good correlation has been established between the concentration
of the receptor and the secretion of ACTH by the pituitary gland
(Aguilera, 1994; Aguilera et al., 1994). Furthermore, increased
expression of AVP mRNA in parvicellular neurons of the PVN
has been demonstrated along with a positive correlation between
the density of corticotroph V1b receptors and ACTH release in
response to chronic stress (Aguilera, 1994).
Numerous studies performed in rats have revealed a shift of
hypothalamic CRH/AVP signal in favor of AVP in some chronic
stress states. This is manifested by enhanced AVP synthesis in
CRH-producing cells in parvicellular neurons of the PVN after
repeated restraint (Whitnall, 1989; De Goeij et al., 1992; Bartanusz
et al., 1993; Aguilera, 1994), foot shock (Sawchenko et al., 1993),
intraperitoneal injection of hypertonic saline (Ma and Aguilera,
1999), and AVP storage in the CRH-containing nerve terminals
in the external zone of the median eminence (De Goeij et al.,
1992). An increased proportion of hypothalamic neurons coex-
pressing AVP has also been demonstrated with such stressors (De
Goeij et al., 1992). At the same time, CRH production remained
unchanged or decreased (De Goeij et al., 1992). CRH expression
increased only in cases of chronic stress when circulating ACTH
and glucocorticoid levels increased, for example, in response to
stress caused by repeated injections of intraperitoneal hyper-
tonic saline or footshock (Imaki et al., 1991; Ma and Aguilera,
1999).
The results of direct manipulation of the HPA axis reinforce
the idea that chronic stress induces a shift of the hypothalamic
CRH/AVP signal in favor of AVP. Prolonged administration of
CRH by osmotic minipumps led to a reduction in CRH receptor
number in the pituitary corticotrophs of control rats (Tizabi and
Aguilera, 1992), which was enhanced by the simultaneous infu-
sion of AVP. At the same time adrenalectomized Brattleboro rats
lacking hypothalamic AVP, showed only a minimal reduction in
CRH receptor number, which was increased by AVP infusion in
the period after adrenalectomy (Tizabi and Aguilera, 1992).
Repeated restraint stress or repeated hypertonic saline injec-
tions were found to produce sustained increases in the expression
of V1b receptor mRNA in the pituitary (Rabadan-Diehl et al.,
1995). This suggests an up-regulation of AVP receptors in situa-
tions of chronic stress, which may explain the preserved enhanced
response to novel superimposed acute stress exposure (so-called
heterotypic stressor) in these animal models. Thus, the study using
V1b receptor knockout mice demonstrated the importance of
AVP and V1b receptor for a normal response of the HPA axis to
heterotypic stressor (hypoglycemia) in chronic stress induced by
repeated restraint (Tanoue et al., 2004; Lolait et al., 2007). In addi-
tion, the plasma ACTH response to repeated mild restraint, forced-
swimming, and novel environments in V1b receptor knockout
mice was decreased in comparison with wild-type mice (Stewart
et al., 2008; Roper et al., 2011).
The sensitivity of CRH and AVP transcription to glucocorticoid
feedback is markedly different (Bilezijian et al., 1987). CRH mRNA
and CRH receptor mRNA levels are reduced by elevated gluco-
corticoids, whereas V1b receptor mRNA levels and coupling of
the receptor to phospholipase C are stimulated by glucocorti-
coids, effects which may contribute to the refractoriness of AVP-
stimulated ACTH secretion to glucocorticoid feedback (Rabadan-
Diehl and Aguilera, 1998; Aguilera and Rabadan-Diehl, 2000).
This suggest that vasopressinergic regulation of the HPA axis
is critical for sustained corticotroph responsiveness in the pres-
ence of high circulating glucocorticoid levels during chronic stress
(Rabadan-Diehl and Aguilera, 1998; Aguilera and Rabadan-Diehl,
2000).
All these findings support the proposal that CRH plays a pre-
dominantly permissive role in the HPA axis regulation in condi-
tions of chronic stress, but AVP is a dynamic modulator of ACTH
release (Plotsky, 1991; Dinan and Scott, 2005).
Some recent studies of chronic stress in naturally AVP-deficient
Brattleboro rats, suggest that the role of V1b and AVP in adapta-
tion of the HPA axis to chronic stress may not be as convincing
as first thought. Experiments on Brattleboro rats and control het-
erozygous littermates utilized three different chronic stress models:
repeated restraint to produce physical–psychological stress (Zelena
et al., 2004; Makara et al., 2012); repeated short periods of mor-
phine withdrawal (Domokos et al., 2008; Makara et al., 2012);
streptozotocin induced diabetes (Zelena et al., 2006; Makara et al.,
2012). The changes characteristic to chronic stress, including body
weight reduction, involution of the thymus, adrenal gland hyper-
trophy, and increases in basal POMC mRNA and plasma corti-
costerone, developed in all three models, but no difference was
observed between the genotypes. Both male AVP-deficient Brat-
tleboro rats and their heterozygous littermates exposed to chronic
unpredictable stress, exhibited elevated levels of POMC mRNA
in the anterior lobe of the pituitary and plasma ACTH along
with a less significant increase in plasma corticosterone (Varga
et al., 2011). In addition, the ACTH and corticosterone response
to repeated shaker stress in V1b receptor knockout mice is not dif-
ferent from that seen in wild-type mice (Roper et al., 2011). There
are also studies using pharmacological models of AVP-deficiency
that have shown adequate HPA axis responses to chronic stress in
the absence of AVP (Chen et al., 2008b). These data suggest that
AVP is not so important for the development of the chronic stress
response.
Perhaps the contradictory results can be explained in terms of
age and species differences in the HPA function of rodents and
primates, including humans. Some evidence suggests that AVP is
the main regulator of the HPA axis during the perinatal period
(Zelena et al., 2008; Makara et al., 2012). And in some key aspects
of HPA function non-human primates are a more appropriate
animal model for human than rodents. For example, the adrenal
cortex of monkeys, in contrast to rodents, produces DHEA and
DHEAS (Goncharova, 1997; Kemnitz et al., 2000; Conley et al.,
2004), which are involved in stress response of the HPA axis and
may regulate the release of AVP (Deuster et al., 2005). It is appar-
ent that we need more in-depth research on the role of AVP in
the HPA axis regulation in response to different types of chronic
stress on various rodent models, including both wild-type and
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homozygous AVP-deficient Brattleboro mutant strains, as well as
V1b receptor knockout rodents. It should also investigate in detail
the function of the HPA axis in AVP-deficient lines in basal condi-
tions using various functional tests to get a solid baseline data that
are comprehensively characterize the artificial models. Extensive
basic research is required on the effects of V1b receptors antago-
nists and agonists on the HPA axis function in resting and stress
conditions in primates.
DEVELOPMENTAL SPECIALTIES OF VASOPRESSINERGIC HPA
AXIS REGULATION
FETAL DEVELOPMENT
Extensive clinical and experimental data indicate variation in the
importance of AVP in regulation of the HPA axis, including its
stress responsiveness, at different stages of ontogeny and under
different physiological conditions. The role of AVP in regulation
of the HPA axis in the fetus has been described only in a few
studies (Carey et al., 2007, 2009). In fetal sheep late in gestation,
secretion of ACTH by the pituitary gland increases in response
to stimulation with AVP. This effect is associated with an increase
in the generation of inositol 1,4,5-trisphosphate, a second mes-
senger of activated V1b receptors (Carey et al., 2007). The same
study also found that hypothalamo-pituitary disconnection signif-
icantly impaired this ontogenetic development and prevents the
developmental increase in fetal plasma cortisol concentrations in
late gestation (Carey et al., 2007). Another study confirmed the
hypothesis that cortisol is an important modulator of pituitary
responsiveness to AVP in the late gestation sheep fetus (Carey
et al., 2009).
NEONATAL PERIOD
Developmental studies have shown that neonatal rodents (Yi and
Baram, 1994; Dent et al., 1999; Schmidt et al., 2009; Zelena et al.,
2011) and humans (Gunnar and Donzella, 2002) show a reduced
adrenocortical response to stress. Thus, this period is called the
stress-hyporesponsive period (Yi and Baram, 1994; Dent et al.,
1999; Schmidt et al., 2009). In some studies the reduced response of
the pituitary–adrenal axis to stressors was not associated with sig-
nificant change in CRH gene transcription (Yi and Baram, 1994) or
even mentioned its decrease in response to certain stressors, such
as endotoxin (Dent et al., 1999). The use of conditional knockout
mice with a deletion of the GR at the pituitary (GRPOMCCre)
showed that during the neonatal period expression of CRH mRNA
in parvicellular neurons of the PVN is reduced while expression
of AVP mRNA is increased (Schmidt et al., 2009). Similar data
were obtained in 10-day-old pups of AVP-deficient Brattleboro
rats, which showed significantly lower resting CRH mRNA lev-
els in the PVN and have revealed that AVP-deficiency abolishes
the ACTH stress response in perinatal rats compared to control
littermates (Zelena et al., 2008). Recent studies by this research
group using the V1b antagonist, SSR149415, confirmed a primary
role for AVP in ACTH stress responsiveness of control rats dur-
ing the neonatal period (Zelena et al., 2011; Makara et al., 2012).
Apparently, the shift in the ratio CRH/AVP in favor AVP (Whit-
nall, 1989; Dinan and Scott, 2005) can take place not only in adult
individuals under chronic stress or acute stress induced by a severe
stressor, as noted in Section “Vasopressinergic Regulation of Stress
Responsiveness of the HPA Axis” above but also in the neonatal
period.
LATE PREGNANCY, LACTATION
Such important physiological conditions of the organism as preg-
nancy and lactation are of considerable interest in terms of vaso-
pressinergic regulation of stress reactivity of the HPA axis. It is well
known that the HPA axis response to stressors is markedly atten-
uated in late pregnancy and during lactation period in women
(Altemus et al., 1995; de Weerth and Buitelaar, 2005) and female
rodents (Fischer et al., 1995; Neumann et al., 1998; Walker et al.,
2001; Ma et al., 2005; Brunton et al., 2008). The precise mecha-
nisms of maternal HPA axis hyporesponsiveness in these two states
are different (see review Brunton et al., 2008), but both states are
characterized by marked changes in AVP secretion from parvicel-
lular neurons of the PVN and subsequent change in the secretion
of ACTH in response to stress. The rat’s response to stress expo-
sure late in pregnancy is associated with reduced AVP expression
(Ma et al., 2005) or reduced expression of both AVP and CRH
(da Costa et al., 1996; Douglas et al., 2003). On the contrary, AVP
mRNA expression in parvicellular neurons of the PVN in post-
partum females exposed to restraint stress during lactation was
greater than that of virgin females (Fischer et al., 1995; Walker
et al., 2001). At the same time, the expression of CRH mRNA in
the PVN significantly decreased during lactation (Fischer et al.,
1995; Shanks et al., 1999; Walker et al., 2001). It suggests that AVP
may play an important role in the stimulation of ACTH secretion
during lactation in rats (Walker et al., 2001). Thus, as in the fetus
and neonate, AVP performs an important role in regulation of the
HPA axis stress reactivity with a shift in the CRH/AVP ratio in
favor of AVP in pregnant and lactating females.
Gestation and early postnatal periods, as we know, are the most
vulnerable periods of ontogenesis in terms of programing disrup-
tions of the HPA axis for adulthood (Schmidt et al., 2009; Long
et al., 2010; Renard et al., 2010) and aging (Goncharova, 2009b;
Solas et al., 2010). Reduced HPA axis response to stressors during
late pregnancy, lactation, and the neonatal period, apparently, is an
adaptive response of the body that provides protection of the fetus
and newborn from an excess of toxic glucocorticoids and that can
also have a programing effect on the development of the HPA axis
and other physiological systems in later life.
AVP IN REGULATION OF HPA AXIS STRESS
RESPONSIVENESS DURING AGING
ACTIVITY OF THE HPA AXIS DURING AGING
It is generally accepted that mainly hyperactivation of the HPA
axis occurs during aging. In small laboratory animals hyperacti-
vation of the HPA axis in the aging process develops at all levels
of the system. Thus, aged rodents demonstrated elevated resting
ACTH and corticosterone plasma levels (Sapolsky et al., 1986; Tiz-
abi et al., 1992; Hauger et al., 1994; Sapolsky, 1999; Meijer et al.,
2005; Lo et al., 2006), an increased release of resting hypothala-
mic CRH (Scaccianoce et al., 1990; Hauger et al., 1994; Sapolsky,
1999), a decreased sensitivity of the adrenal glands to ACTH (Tang
and Phillips, 1978; Sapolsky et al., 1986), of the anterior pitu-
itary to CRH (Hylka et al., 1984; Sapolsky et al., 1986; Hauger
et al., 1994; Sapolsky, 1999), of the pituitary, hippocampus, and
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hypothalamus to the level of circulating glucocorticoids (Sapol-
sky et al., 1986; Tizabi et al., 1992; Hatzinger et al., 2000; Revskoy
and Redei, 2000). In old rodents, hyperactivity of the HPA axis is
likely to reflect loss of resiliency and reduced sensitivity to nega-
tive glucocorticoid feedback, which mainly reflects hippocampal
receptor damage (Sapolsky et al., 1986; Seeman and Robbins, 1994;
Pedersen et al., 2001; Giordano et al., 2005). As a result, older ani-
mals tend to show a more prolonged elevation of corticosterone
in response to stress exposure (Sapolsky et al., 1986; Seeman and
Robbins, 1994; Sapolsky, 1999). Marked disturbances have been
shown in the reaction of aged rat adrenals to stress.
These have been expressed mainly as increases in the maximum
peak values of plasma corticosterone rise and the prolongation of
elevated corticosterone secretion (Sapolsky et al., 1986; Seeman
and Robbins, 1994; Sapolsky, 1999; Lo et al., 2006). Some studies,
however, have shown individual and species differences ranging
from unchanged and reduced basal and stress responses in aged
rats compared to young rats (Cizza et al., 1994; Hauger et al., 1994;
Lightman et al., 2000).
Hyperactivation of the HPA axis during aging in humans and
non-human primates is generally associated with elevated plasma
levels of ACTH and cortisol in basal conditions (Sapolsky and Alt-
man, 1991; Guazzo et al., 1996; Lupien et al., 1999, 2007). Decrease
in HPA axis sensitivity to glucocorticoid regulation by a feedback
mechanism with age has also been observed in humans (Born
et al., 1995; Heuser et al., 2000; Giordano et al., 2005) and non-
human primates (Sapolsky and Altman, 1991; Brooke et al., 1994;
Goncharova et al., 2000; Gust et al., 2000; Goncharova and Lapin,
2002, 2004). However, in contrast to rodents there was an increase
in response of the pituitary–adrenal axis to CRH and ACTH injec-
tion in humans (Born et al., 1995; Kudielka et al., 1999; Ferrari
et al., 2001) and monkeys (Goncharova and Lapin, 2002, 2004;
Goncharova et al., 2002), as was a higher responsiveness of the
pituitary–adrenal axis to combined administration of CRH and
AVP (Born et al., 1995). With healthy aging basal activity of CRH-
producing neurons in the hypothalamic PVN slightly increased in
the human (see review Swaab et al., 2005).
It should be noted that aging is associated with an increase in
the variability of disturbances in the HPA axis both in primates
and rodents but to a greater extent in humans and non-human
primates than in rodents. Many authors have failed to observe
significant age-related changes in basal plasma levels of ACTH
and cortisol in humans (Ohashi et al., 1986; Waltman et al., 1991;
Goncharova, 1997; Goncharova et al., 2002) and monkeys (Moore
et al., 1979; Goncharova and Lapin, 2000, 2002; Goncharova et al.,
2000; Kemnitz et al., 2000). Some even have observed decreased
basal cortisol levels in humans (Blichert-Toft, 1978; Sherman et al.,
1985) and monkeys (Gust et al., 2000). Other researchers have
found no marked age-related changes in sensitivity of the HPA
axis to inhibition by glucocorticoid feedback (Blichert-Toft, 1978;
Waltman et al., 1991; Huizenga et al., 1998). There was no change
in the reaction of the adrenal cortex to injection of CRH, ACTH,
or insulin in humans (Blichert-Toft, 1978; Ohashi et al., 1986) or
non-human primates (Goncharova and Lapin, 2000; Goncharova
et al., 2000).
Some researchers have found higher responses to acute
psycho-emotional stress in physically untrained aged individuals
(Traustadóttir et al., 2005). Older men responded to psychological
stress with increased cortisol levels and more intense cardiovas-
cular responses compared to women of similar age (Traustadottir
et al., 2003). Comparative analysis of cortisol response to various
pharmacological stimuli including dexamethasone, CRH, nalox-
one,ACTH, insulin, epinephrine, metapyrone, physostigmine, and
hypertonic saline, as well as to psychological stressors in healthy
volunteers, young and old age through the analysis of the data
published by different authors in 45 articles, allowed the authors
(Otte et al., 2005) to come to a conclusion about a higher HPA
axis response in older subjects compared to younger persons. The
effect of age on the release of cortisol was significantly greater in
women.
At the same time, no age-related differences in ACTH and
cortisol levels in response to acute psychosocial stress have been
reported in postmenopausal women compared to young women
(Kudielka et al., 1999). The response to acute psychological stress
in the elderly who were aerobically fit did not differ from that
of young adults (Traustadóttir et al., 2005). Marked difference in
function of the HPA axis in response to surgical stress is not seen
between young persons and centenarians (Kudoh et al., 2001),
even though clinical observations indicate that the mortality rate
of elderly patients, undergoing surgery is much higher than that of
young patients (Blichert-Toft, 1978). The higher rate may be due
to reduced adaptive ability of the aging body and deterioration of
HPA axis function.
Experiments on healthy non-human primates (Macaca
mulatta) revealed that age-related dysfunctions of the HPA axis
are associated with adaptive behavior of animals (Goncharova
et al., 2010). Monkeys with depression-like behavior show age-
related changes in the HPA axis function that are accompanied
by maximal absolute and relative hypercortisolemia (high corti-
sol/DHEAS molar ratio) under resting conditions, as well as by a
significantly greater increase in plasma cortisol levels with acute
psycho-emotional stress. Young aggressive monkeys, in compari-
son with young monkeys of other behavior groups, demonstrated
the highest plasma levels of DHEAS and the lowest molar ratios
of cortisol to DHEAS. Such differences were not exhibited by old
monkeys with aggressive behavior. Minimal age-related changes
in the HPA axis have been observed in monkeys with average
(standard) behavior.
It should be noted that a striking difference in physiology of
the HPA axis between primates and rodents is the secretion of
large amounts of DHEA and DHEAS by the primate adrenal cor-
tex, which undergoes a decline with age (Orentreich et al., 1992;
Goncharova, 1997; Yen and Laughlin, 1998; Ferrari et al., 2001;
Goncharova and Lapin, 2002; Conley et al., 2004; Heaney et al.,
2012). DHEA and DHEAS serve as precursors to androgens and
estrogens (Yen and Laughlin, 1998; Labrie et al., 2001; Mellon and
Vaudry, 2001). In addition, they may act as functional antago-
nists to the effects of glucocorticoids (Yen and Laughlin, 1998;
Maninger et al., 2009). In the brain, they are neuromodulators of
neuronal receptors, such as GABA-A and N -methyl-d-aspartate
(NMDA) receptors (Baulieu, 1998; Yen and Laughlin, 1998; Mel-
lon and Vaudry, 2001), which are part of the neurons of afferents
nerves regulating – among others – the PVN activity (Arvat et al.,
2002; Deuster et al., 2005).
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CIRCADIAN RHYTHMS
Significant variability has been found with respect to age-related
changes in circadian rhythms of ACTH and glucocorticoid secre-
tion both in humans and animals. While a number of studies have
failed to show marked circadian disorders of cortisol and ACTH in
humans and non-human primates (Chambers et al., 1982; Walt-
man et al., 1991; Ceresini et al., 2000) and some strains of rats
(Honma et al., 1996), an increasing number of studies have shown
disruption of circadian rhythms in HPA axis activity with aging
in both humans and animals. Many authors have reported age-
associated increases in basal ACTH and cortisol concentrations
in terms of basal evening levels and nadirs in humans (Ferrari
et al., 2001; Giordano et al., 2005; Hofman and Swaab, 2006) and
non-human primates (Gust et al., 2000; Khavinson et al., 2001;
Goncharova et al., 2002, 2006b; Zhdanova et al., 2011), and fall of
the levels of ACTH and corticosterone in the evening and increase
during the circadian trough in rodents (Hauger et al., 1994; Light-
man et al., 2000; Froy, 2011). A damaged daily rhythm may involve
the SCN, as fetal transplants containing SCN can restore the
circadian rhythm in old Sprague-Dawley rats (Cai et al., 1997).
The master circadian clock is located in the SCN of the hypo-
thalamus. Its activity is synchronized with the natural day–night
cycle, and it coordinates the circadian rhythms of the body, includ-
ing the HPA axis rhythm (Reppert and Weaver, 2002; Kalsbeek
et al., 2010; Walker et al., 2010; Kondratova and Kondratov, 2012).
A characteristic feature of the SCN in many species, including
humans and other primates is a subpopulation of AVP-containing
neurons (Kalsbeek et al., 2010). The SCN regulates HPA axis activ-
ity through the PVN via AVP, which serves as a neurotransmitter
in the SCN afferents to the hypothalamic PVN (Kalsbeek et al.,
2010). The regulatory function of these afferents is confirmed by
experiments with microinjections of AVP-cytotoxic monoclonal
antibodies into the SCN, which produce a significant reduction of
immunoreactive AVP and AVP mRNA expression there as well as
in parvicellular neurons of the PVN (Gomez et al., 1997). Study
of post-mortem human brains revealed a pronounced circadian
variation in the activity of AVP-containing neurons in the SCN
(Kalsbeek et al., 2010). Animal experiments have shown an impor-
tant role for SCN-derived AVP in the control of neuroendocrine
day/night rhythms of the HPA axis (Kalsbeek et al., 2010). The
number of AVP-expressing neurons in the SCN declines with age
in humans (Swaab et al., 1985), non-human primates (Cayetanot
et al., 2005), and rats (Roozendaal et al., 1987). Decreased AVP-
producing neurons in the SCN in aged humans and animals are
accompanied by deterioration of the circadian rhythms of HPA
axis function (Kalsbeek et al., 2010).
AVP REGULATION OF STRESS RESPONSIVENESS OF THE HPA AXIS
WITH AGING
Age-related changes in AVP production vary depending on loca-
tion in the brain. While secretion of AVP decreases with aging in
the SCN of animals and humans (Cai et al., 1997; Cayetanot et al.,
2005; Hofman and Swaab, 2006; Kalsbeek et al., 2010), its secretion
in the PVN seems to increase. This is indicated by immunocyto-
chemical studies of human post-mortem brains that have revealed
increased amounts of AVP in AVP-expressing cells and in the size
of AVP-containing neurons in the PVN of aged humans (Lucassen
et al., 1993; Prelevic and Jacobs, 1997; Ishunina and Swaab, 1999).
In addition, an age-dependent change in colocalization of CRH
and AVP in favor of AVP in the human PVN has been identified
(Raadsheer et al., 1993). Moreover, old rats showed signs of hyper-
active AVP-expressing neurons (Terwell et al., 1992; Bazhanova
et al., 2000). Other studies, however, provide indications of a mod-
est activation of CRH neurons with aging in healthy persons (see
review Swaab et al., 2005).
In the literature there are several studies that investigated the
role of the AVP/V1b receptor system in the regulation of stress
responsiveness of the HPA axis with aging. Most of these studies
have been performed in experiments on rodents. Features of vaso-
pressinergic regulation of stress responsiveness of the HPA axis
during aging has been studied significantly less in humans and
non-human primates.
Rodents
On the other hand, the idea that secretion of AVP in the PVN can
increase with aging is evidenced by the results of studies on the
role of AVP in the regulation of stress reactivity of the HPA axis,
performed mainly on rodents. Thus, some reports in the literature
describe work with rats of the Fischer-344/N strain, in which aging
is associated with a progressive decline in hypothalamic CRH pro-
duction associated with increased production of AVP (Cizza et al.,
1994). In this case, basal plasma ACTH levels were similar across
age groups. Injection of exogenous rat CRH elicited significantly
greater ACTH and corticosterone responses in aged rats, which
was consistent with the observation of hypothalamic CRH defi-
ciency. CRH mRNA levels in the PVN, CRH content, and in vitro
secretion of CRH by whole explanted hypothalamus showed pro-
gressive and significant reductions with age, whereas the steady
state levels of AVP mRNA significantly increased with age (Cizza
et al., 1994). Perhaps the importance of PVN-derived AVP for HPA
axis regulation increases with advancing age, while the importance
of CRH is reduced.
Subsequent studies have confirmed the important role of AVP
expressed in parvicellular neurons of the PVN in the regulation of
ACTH secretion in response to stimulus. Application of the com-
bined DEX/CRH test to old male Wistar rats resulted in excessive
release of ACTH and corticosterone as compared to young rats.
Administration of a V1b receptor antagonist between the dex-
amethasone and CRH injections blocked the effect (Hatzinger
et al., 2000). In DEX-pretreated aged rats the authors detected
increased numbers of AVP mRNA-expressing neurons in the PVN;
this was in combination with increased numbers and activity of
CRH mRNA-expressing neurons. This study provided the first
direct evidence of the involvement of excessive activity of AVP-
expressing neurons in age-dependent hyperactivity of the HPA
axis. The results of this study suggest an important role of AVP in
the mechanism of increased HPA axis activity in aging rats, pos-
sibly secondary to defective function of corticosteroid receptors
(Hatzinger et al., 2000).
Another study has demonstrated an increase in the content
of AVP within the PVN in basal conditions. The approximately
twofold increase correlated with an increase of ACTH and cor-
ticosterone basal plasma levels in old rats (Keck et al., 2000).
However, in response to acute stressor, forced-swimming, the
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responses of AVP, ACTH, and cortisol were significantly lower
than in young animals (Keck et al., 2000). Some authors report
that aging in rats is likely to be associated with reduced production
of AVP and hypersecretion of CRH in the hypothalamus and sub-
sequent down-regulation of corticotroph CRH receptor (Hauger
et al., 1994).
Some of the contradictory results reported in the above papers
may by attributable to individual differences in HPA axis function
both in resting and stress conditions. Thus, in the study of Meijer
et al. (2005) young and aged rats had previously been classified as
inferior and superior learners on the basis of their performance
in a water maze test. The authors tested for a correlation between
the production of the hypothalamic neuropeptides, CRH and AVP,
and their status as inferior and superior learners. They found that
AVP expression in parvicellular neurons of the PVN was virtually
unchanged with aging in animals of either group. CRH expres-
sion, however, decreased significantly in old animals compared to
young animals in the superior learning group, which produced
a change in the ratio of CRH/AVP expression in favor of AVP.
By contrast, the ratio of CRH/AVP expression in inferior learners
was virtually unchanged with aging. Apparently, there are marked
individual differences in rats of the same strain, as well as differ-
ences between strains in aging of the brain in general and aging
of the HPA axis in particular. This conclusion is supported by the
results of studies that demonstrate differences in the functioning
of the HPA axis in adult rats of the same species with high and
low trait anxiety (Keck et al., 2002). Using surgical microdialysis
in vivo, the investigators showed that the content of AVP in the
PVN is significantly higher in rats with increased anxiety (Keck
et al., 2002).
Thus, reports on the possible role of the AVP/V1b receptor sys-
tem in the increase of HPA axis hyperactivity with aging in rodents
are contradictory, suggesting (a) the possible increase of the AVP
production in the PVN for aged rodents, (b) the possible lack of
any age changes in the AVP secretion in basal and stress conditions,
and (c) the possible reduced basal AVP production along with the
CRH hypersecretion.
Humans and non-human primates
Only a few studies have addressed age-related changes in vaso-
pressinergic regulation of HPA axis stress reactivity in humans
and non-human primates (Raskind et al., 1995; Deuster et al.,
2005; Goncharova, 2009a). Most studies have focused on age dif-
ferences in response of the pituitary–adrenal axis to stress. The
cross-species findings are quite variable with regard to respon-
siveness of the HPA axis in old age. They depend not only on
the nature, intensity and duration of exposure of the stressor, the
genetic characteristics of the individual, and the environment in
old age, but also on the influence of genetic and environmental
factors in the early stages of development, particularly the fetal
and neonatal periods. Environmental stress in early life may pro-
gram the future development, including disruptions of HPA axis
stress responsiveness in old age (Pivina et al., 2007; Goncharova,
2009b; Solas et al., 2010).
It has been noted that the healthy elderly exhibit a more pro-
nounced adrenocortical response to hypertonic saline infusion
than young people (Raskind et al., 1995). The increase in levels
of AVP and plasma osmolarity was similar in representatives of
both age groups, but no rise in the levels of ACTH was observed in
either older or young subjects. The authors, therefore, suggested
that the increased cortisol secretion in response to stimulation
with the hypertonic solution was due to age-related changes in the
adrenocortical level of the HPA axis (Raskind et al., 1995). Perhaps,
stimulation of cortisol secretion was influenced by increased levels
of AVP in the general circulation. This effect could be a direct AVP
effect on the adrenal gland as the pituitary contains predominantly
V1b receptor, but the adrenal cortex has V1a receptor (Grazzini
et al., 1996; Vezzosi et al., 2007; Roper et al., 2011). Thus, there is
evidence that AVP potentiates cortisol secretion in vitro by normal
human adrenal cortex and some cortisol-producing adrenocorti-
cal tumors or hyperplasia through the activation of V1a receptors
(Perraudin et al., 1993, 1995).
Interestingly, chronic administration of DHEA to healthy
young men significantly increased exercise-induced release of AVP
along with ACTH and cortisol secretion (Deuster et al., 2005).
Perhaps, the stimulating effect of DHEA on pituitary–adrenal axis
stress responsiveness is due to its action as antagonist of GABA-
A receptors restrained the HPA axis and the stimulating effect of
DHEA on NMDA receptors, involved in AVP release (Rossi and
Chen, 2002; Deuster et al., 2005). In this regard, DHEA deficiency
during aging in humans and non-human primates may play an
important role in development of the age-related disturbances
of the HPA axis and, in particular, of its stress responsiveness
(Kudielka et al., 1998; Goncharova et al., 2000).
Recent experiments on non-human primates (Goncharova,
2006, 2009a; Goncharova et al., 2006a, 2008b), had shown that
stress responsiveness of the HPA axis depends to a large extent on
the time of day when stimulus is applied as well as on initial sen-
sitivity of the HPA axis. It was shown that the circadian rhythm
of ACTH and cortisol level is evident not only in basal condi-
tions but also in response to acute psycho-emotional stress. Young
(6–8 years old) female rhesus monkeys showed a much higher
increase in ACTH and cortisol levels in response to a 2 h restraint
stress imposed at 15:00 h than to the same stress imposed at
09:00 h. This difference attenuates with aging. Old (20–27 years
old) female animals showed much lower responsiveness of the
HPA axis to the afternoon stress and a tendency toward higher
responsiveness to the morning stress. A similar circadian rhythm
in responsiveness of the HPA axis to mild acute stress was observed
in young pregnant women (De Weerth et al., 2007). The time-
dependent responsiveness of the HPA axis to acute immobilization
stress was observed in young male Papio hamadryas (Chirkov et al.,
1987) and young female Wistar rats (Pivina et al., 2007). More-
over, senescent rats demonstrated flattening of circadian rhythm
in stress reactivity of the HPA axis (Pivina et al., 2007).
The attempt to understand the mechanism of decreasing stress
reactivity of the pituitary–adrenal axis with aging led to a series of
experiments with the administration of a standard dose of CRH
and AVP (1µg/kg b.w., intravenously) to young and old female
rhesus monkeys at different times of day (09:00 and 15:00 h). The
response of the pituitary–adrenal axis to the injection of CRH
revealed a circadian rhythm with a more pronounced response
in the afternoon; this rhythm was not affected by aging (Gon-
charova, 2009a). Apparently, the circadian rhythm in the secretion
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of CRH underlies the circadian rhythm in the stress reactivity of
the pituitary–adrenal axis of the HPA axis. At the same time, the
rise of ACTH and cortisol levels in response to AVP injection did
not show a dependence on the time of the day in either young
or old animals. A significant age-related difference in the rise of
ACTH and cortisol in response to AVP injection was, however,
found in the response to AVP administered in the afternoon; lower
values were seen in older animals (Goncharova, 2009a). It appears
that age differences in response of the anterior pituitary to AVP
may underlie age-related differences in stress responsiveness of the
HPA axis in primates in the afternoon. Perhaps age differences in
response of the anterior pituitary to AVP underlie age-related dif-
ferences in stress responsiveness of the HPA axis in primates in the
afternoon.
CONCLUSION
(1) The role of CRH and AVP in the stimulation of ACTH secre-
tion varies depending upon the species. For humans, non-
human primates, and rats CRH seems to be a more important
secretagogue than AVP, in humans, all parvicellular neurons
of the PVN, which produce CRH in the basal conditions, pro-
duce AVP as well, whereas in rats not more than half produce
AVP.
(2) AVP is an important regulator of the ACTH response to acute
stress. AVP contributes to the acute ACTH secretion to stress in
a context-specific manner. AVP is needed for the acute ACTH
secretion for most of the known stressors.
(3) Current data on the role of AVP in the regulation of
HPA axis responsiveness to chronic stress in adulthood are
contradictory and require further research.
(4) The importance of the vasopressinergic regulation of stress
responsiveness of the HPA axis is elevated during the fetal
development, in neonatal period, and in the lactating adult.
(5) (a) Aging is associated with increased variability in several
parameters of HPA axis function including basal state,
responsiveness to stressors, and special testing. This
increased variability in the aged compared to normal
adults has been observed in some form in multiple species
including rodents, non-human primates, and humans.
(b) For the most experiments on rodents, the hyperactiva-
tion of the HPA axis was observed at all levels of the
HPA organization with aging under the basal and stress
conditions.
(c) With healthy aging of non-human primates and humans
the HPA hyperactivation is usually associated with the
increase of the cortisol level in the evening time, the
slight changes in the regulation of the HPA axis by glu-
cocorticoid feedback with relative hypercortisolemia due
to the decline in secretion of the adrenal antagonists of
cortisol – DHEA and DHEAS.
(6) Reports on the possible role of the AVP/V1b receptor sys-
tem in the increase of HPA axis hyperactivity with aging are
contradictory, suggesting
(a) the possible increase of the AVP production in the PVN
for aged rodents and humans,
(b) the possible lack of any age changes in the AVP secretion
in basal and stress conditions,
(c) the possible reduced basal AVP production along with the
CRH hypersecretion.
(7) Age-related changes in response of the HPA axis to the
moderate acute restraint stress were observed in rhesus
monkeys with much higher increase of ACTH and corti-
sol secretion in young monkeys in response to the stress
imposed at 15:00 h. In addition, these age changes were
associated with age-related disturbances in vasopressinergic
regulation.
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